- Adds complementary training services to provide holistic customer support
- Deepens experience with high quality medical device consulting team
- Follows acquisitions of DataRevive and IDEC in 2019 and 2020 respectively
SAN FRANCISCO, CA – (BUSINESS WIRE) – April 15, 2021 – Validant, a leading transatlantic quality, compliance and regulatory consulting group, has acquired Oriel STAT A MATRIX (‘Oriel’), a global consultancy and training firm for the medical device industry.
Headquartered in New Jersey, Oriel provides regulatory, quality and compliance consulting as well as training for the medical device industry. Oriel is an industry leader in quality, compliance and auditor training for the medical device industry, with the largest library of content in the market and relationships with 90% of the top 10 medical device companies globally. The business leverages a combination of in-person and virtual training courses, ensuring customers have access to knowledge whenever and wherever needed, delivered by industry leading instructors.
Validant’s acquisition of Oriel is another important step in its international growth strategy, focused on combining best-in-class regulatory and quality providers, and continuing their aggressive growth with further investment. It follows the acquisitions of DataRevive in 2019, a regulatory strategy and consultancy for global clients, and IDEC in 2020, a regulatory consultancy based in Tokyo.
The acquisition will expand the Validant Group’s proposition into training services as well as adding further depth in regulatory consulting with the integration of an experienced team. The combination will also provide customers with increased access to industry leading consultants and solutions across the product lifecycle.
Commenting on the announcement, Brian Burns, President of Validant said: “It is my pleasure to announce the acquisition of Oriel STAT A MATRIX. Under the leadership of Alan Marash and Judith Glaser Marash, Oriel has developed into a leading training provider for medical device customers. We are delighted to be adding this high-quality team and complementary training services to the Validant Group’s combined proposition as we cement our position as the leading quality, compliance and regulatory consulting firm in the life science sector globally.”
Alan Marash, CEO of Oriel, said: “With complementary services and shared experience within the medical device industry, we’re delighted to be partnering with Validant on the next stage of Oriel’s growth journey. I look forward to working with Chad Hedlund who was promoted to President of Oriel STAT A MATRIX and the Validant team to increase the support that we can provide to our clients across the full suite of regulatory, compliance and training services, as well as the potential to expand our geographic footprint into new markets.”
Fairmount Partners provided investment banking and advisory services, Bailey & Glasser provided legal advice and Bruce Gendelman Insurance provided insurance advice to the shareholders of Oriel STAT A MATRIX.
OMM provided legal advice, RSM Global provided financial and accounting advice, Deloitte provided tax advice, and Atlantic Global Risk Corporation provided insurance advice to Validant.
Validant is a leading international Quality, Compliance, and Regulatory consulting firm, blending industry expertise with innovation to create custom solutions for companies on the frontier of health. With deep experience working within and alongside the FDA and other regulatory agencies, we understand how to navigate the complexities facing today’s healthcare industry. For further information, please visit www.validant.com
About Oriel STAT A MATRIX
Founded in 1968 and headquartered in Union, New Jersey, Oriel STAT A MATRIX is global provider of quality and regulatory consulting and training solutions for medical device, IVD and combination product manufacturers. Our purpose is to help Life Science organizations interpret, understand, and apply regulations by transferring knowledge and skills in a manner that enables our clients to place high quality medical products on the market faster, ultimately improving patient outcomes and quality of life. For further information, please visit www.orielstat.com
About Fairmount Partners
Fairmount Partners (www.fairmountpartners.com) is an independent merger and acquisition advisory firm focused on emerging growth and middle-market companies. Fairmount helps its clients complete mergers and acquisitions; raise funds for growth, acquisitions and liquidity; and design and improve their corporate development strategies. Fairmount’s clients include successful entrepreneurs, private equity-sponsored enterprises, and global public companies. Since 2003, Fairmount has completed more than 240 transactions, representing over $12 billion in aggregate value, in 20 countries throughout North and South America, Europe, Asia and Australia. For further information, please contact Neal McCarthy at firstname.lastname@example.org.